Physician profile
Jeffery D Vaught
NPI 1245244961
$1,833.38
in general payments reported to CMS, 2019-2025
30 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $52.82 · 2022: $316 · 2023: $587 · 2024: $497 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $216.40 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $211.52 | 2019-2023 | Provenge |
| Axonics, INC. | $174.07 | 2022 | |
| Genzyme Corporation | $112.49 | 2022-2023 | |
| Tolmar, INC. | $101.64 | 2023-2024 | |
| Janssen Biotech, INC. | $98.82 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $62.81 | 2023-2024 | |
| Astellas Pharma US INC | $62.04 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $59.00 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $58.97 | 2024 | Aquabeam System |
| Medtronic, INC. | $58.12 | 2024-2025 | Interstim |
| Astrazeneca Pharmaceuticals LP | $57.05 | 2023 | Lynparza |
| Progenics Pharmaceuticals, INC. | $48.90 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $48.62 | 2023 | Bard Urinary Drainage Bag |
| Abbvie INC. | $46.28 | 2023-2025 | Lupron Depot |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $45.48 | 2023 | Jelmyto |
| Sun Pharmaceutical Industries INC. | $44.82 | 2023-2024 | Yonsa |
| Merck Sharp & Dohme LLC | $38.92 | 2023-2024 | Keytruda |
| Endo Pharmaceuticals INC. | $37.07 | 2019-2024 | Aveed, Xiaflex |
| Myriad Genetic Laboratories, INC. | $33.66 | 2023-2025 | Prolaris |
| Coloplast Corp | $30.24 | 2022-2023 | Speedicath |
| Ferring Pharmaceuticals INC. | $28.10 | 2019-2020 | |
| Blue Earth Diagnostics | $26.59 | 2020 | |
| Accord Healthcare, INC. | $25.77 | 2023 | |
| Inspire Medical Systems, INC. | $24.79 | 2024 | Inspire |
| Amgen INC. | $22.63 | 2022 | |
| Bioprotect Medical, INC. | $16.09 | 2025 | Bioprotect Balloon Implant System |
| Cook Medical LLC | $16.02 | 2023 | Tornado |
| Olympus America INC. | $15.09 | 2025 | Itind System |
| Allergan, INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Vaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.